Keyphrases
National Institutes of Health
100%
Single Technology Appraisal
100%
Dravet Syndrome
100%
Fenfluramine
100%
Evidence Review
100%
Convulsive Seizures
50%
Cannabidiol
41%
Caregivers
33%
Seizure Frequency
33%
Seizure
16%
Randomized Trial
16%
Antiepileptic Drugs
16%
Cost-effectiveness
16%
Economic Model
16%
Registration Trial
16%
Appraisal Processes
16%
Group Reports
16%
Treatment Effect
8%
Placebo
8%
Maastricht University
8%
Bayesian Analysis
8%
University Medical Centre
8%
Model Costs
8%
Patient Needs
8%
Study within a Trial
8%
Percentage Reduction
8%
Clinical Efficacy
8%
Incremental Cost-effectiveness Ratio
8%
EQ-5D
8%
Frequency Rate
8%
Seizure-free
8%
Clobazam
8%
Patient-level Data
8%
Clinical Costs
8%
Technology Assessment
8%
Utility Value
8%
Parental Impact
8%
National Health Service
8%
Open-label Extension
8%
State Transition Model
8%
Health Economic Model
8%
Committee Meetings
8%
R Statistical Software
8%
Pediatric Quality of Life Inventory
8%
EQ-5D-Y-3L
8%
Number of Patients
8%
INIS
reviews
100%
appraisal
100%
patients
87%
utilities
50%
cost
37%
economics
37%
data
25%
reduction
25%
levels
12%
doses
12%
values
12%
drugs
12%
computer codes
12%
comparative evaluations
12%
quality of life
12%
pediatrics
12%
mapping
12%
people
12%
universities
12%
inventories
12%
transparency
12%
medical centers
12%
health services
12%
medicines
12%
Medicine and Dentistry
Fenfluramine
100%
Severe Myoclonic Epilepsy of Infancy
100%
Epileptic Seizure
66%
Cannabidiol
41%
Cost-Effectiveness Analysis
25%
Systematic Review
16%
Placebo
8%
Retrospective Study
8%
Medicine
8%
Prospective Study
8%
Base
8%
Treatment Effect
8%
National Health Service
8%
Anticonvulsant
8%
Arm
8%
Network Meta-Analysis
8%
Clobazam
8%
Nursing and Health Professions
Fenfluramine
100%
Severe Myoclonic Epilepsy in Infancy
100%
Cannabidiol
41%
Systematic Review
16%
Cost Effectiveness Analysis
16%
Base
8%
University Hospital
8%
Socialized Medicine
8%
Clinical Effectiveness
8%
Incremental Cost-Effectiveness Ratio
8%
Placebo
8%
Anticonvulsive Agent
8%
Network Meta-Analysis
8%
Electroretinogram
8%
Clobazam
8%
Health Economics
8%
Pharmacology, Toxicology and Pharmaceutical Science
Fenfluramine
100%
Severe Myoclonic Epilepsy in Infancy
100%
Cannabidiol
41%
Placebo
8%
Prospective Study
8%
Base
8%
Anticonvulsive Agent
8%
Retrospective Study
8%
Clobazam
8%